Menu Search
Equities

Kobayashi Pharmaceutical Co Ltd

4967:TYO

Kobayashi Pharmaceutical Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)5,584.00
  • Today's Change147.00 / 2.70%
  • Shares traded439.50k
  • 1 Year change-19.61%
  • Beta0.1657
Data delayed at least 20 minutes, as of Sep 19 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy0
Outperform1
Hold5
Sell0
Strong Sell1

Share price forecast in JPY

The 8 analysts offering 12 month price targets for Kobayashi Pharmaceutical Co Ltd have a median target of 5,850.00, with a high estimate of 9,800.00 and a low estimate of 4,800.00. The median estimate represents a 4.76% increase from the last price of 5,584.00.
High75.5%9,800.00
Med4.8%5,850.00
Low-14.0%4,800.00

Dividends in JPY

In 2023, Kobayashi Pharmaceutical Co Ltd reported a dividend of 101.00 JPY, which represents a 12.22% increase over last year. The 7 analysts covering the company expect dividends of 102.86 JPY for the upcoming fiscal year, an increase of 1.84%.
Div growth (TTM)12.22%
More ▼

Earnings history & estimates in JPY

On Aug 08, 2024, Kobayashi Pharmaceutical Co Ltd reported 2nd quarter 2024 earnings of 6.19 per share.
The next earnings announcement is expected on Nov 05, 2024.
Average growth rate-22.21%
Kobayashi Pharmaceutical Co Ltd reported annual 2023 earnings of 268.16 per share on Feb 09, 2024.
Average growth rate+2.39%
More ▼

Revenue history & estimates in JPY

Kobayashi Pharmaceutical Co., Ltd. had 2nd quarter 2024 revenues of 36.65m. This missed the 38.36m consensus estimate of the 3 analysts following the company. This was 9.51% above the prior year's 2nd quarter results.
Average growth rate+0.08%
Kobayashi Pharmaceutical Co., Ltd. had revenues for the full year 2023 of 173.46m. This was 4.33% above the prior year's results.
Average growth rate+1.03%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.